Novomics Co (XKRX:283100) Change In Receivables : ₩42.2 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Change In Receivables?

Novomics Co's change in receivables for the quarter that ended in Dec. 2024 was ₩42.2 Mil. It means Novomics Co's Accounts Receivable declined by ₩42.2 Mil from Dec. 2023 to Dec. 2024 .

Novomics Co's change in receivables for the fiscal year that ended in Dec. 2024 was ₩42.2 Mil. It means Novomics Co's Accounts Receivable declined by ₩42.2 Mil from Dec. 2023 to Dec. 2024 .

Novomics Co's Accounts Receivable for the quarter that ended in Dec. 2024 was ₩0.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Novomics Co's Days Sales Outstanding for the six months ended in Dec. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Novomics Co's liquidation value for the six months ended in Dec. 2024 was ₩-14,579.8 Mil.

Novomics Co Change In Receivables Historical Data

The historical data trend for Novomics Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co Change In Receivables Chart

Novomics Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-63.15

49.58

-0.64

93.14

42.19

Novomics Co Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Change In Receivables	Get a 7-Day Free Trial			-63.15	49.58	-0.64	93.14	42.19

Novomics Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 was ₩42.2 Mil.

Novomics Co (XKRX:283100) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Novomics Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	128.55	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Novomics Co's accounts receivable are only considered to be worth 75% of book value:

Novomics Co's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	508.119	-	15097.526	+	0.75 * 0	+	0.5 * 19.267
=	-14,579.8

Novomics Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Novomics Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Novomics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR

Website

http://www.novomics.com

Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines